Orange Book product · Generic (ANDA)
AMINOCAPROIC ACID
AMINOCAPROIC ACID
At a glance
Aug 28, 2025
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 28, 2025
10 mo ago
Today
Pharmaceutical detail
Active ingredient
AMINOCAPROIC ACID
Strength
250MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 215374
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMINOCAPROIC ACID
- 2004AMICARBrand (NDA)
NDA 015197 · HIKMA
- 1982AMINOCAPROIC ACIDBrand (NDA)
NDA 018590 · BAXTER HLTHCARE
- —AMICARBrand (NDA)
NDA 015229 · EPIC PHARMA LLC
- —AMICARBrand (NDA)
NDA 015230 · HIKMA
- 2025AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213216 · SCIEGEN PHARMS
- 2024AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 215100 · MSN
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213213 · SUNNY
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 212938 · MSN
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 214458 · TARO
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 216464 · ANNORA PHARMA
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 216804 · AUROBINDO PHARMA
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213944 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
